Research Programs |
|||
| Molecular Biochemical Etiology | Cancer Genes and Molecular Regulation | ||
|
Researchers in this program stimulate collaborative multidisciplinary research to further our understanding of the molecular and biochemical events leading to oncogenesis and to develop strategies for abrogating these events. |
Members in this program study the mechanisms that cause cells
to become malignant and form tumors. |
||
|
|
|
|
|
|
James Shull, PhD Chair of the Department of Genetics, Cell Biology and Anatomy |
Hamid Band, MD, PhD Professor, Eppley Institute for Research in Cancer and Allied Diseases |
Robert Lewis, Ph.D. Professor, Eppley Institute for Research in Cancer and Allied Diseases |
Jean Grem, MD Professor, Hematology / Oncology |
|
402-559-4633
jshull@unmc.edu |
402-559-8572 hband@unmc.edu | 402-559-8290 rlewis@unmc.edu | 402-559-3233 jgrem@unmc.edu |
|
Lymphoma Research |
Cancer Prevention and Control | ||
|
Research in this program is focused on identifying causes,
evaluation of molecular markers of prognosis, and
development of new therapies for hematological malignancies. |
Members in this developing program focus on improving the current knowledge base for promoting overall reductions in cancer incidence, morbidity, and mortality, as well as conducting research on reducing cancer risk and incidence, reducing complications secondary to cancer, managing symptoms and improving quality of life and survivorship. |
||
|
|
|
|
|
|
Wing Chung (John) Chan, MD Professor, |
Julie Vose, MD Chief, Section of Hematology / Oncology |
Ann M. Berger, PhD, RN, AOCN, FAAN |
Shinobu Watanabe-Galloway, PhD Assistant Professor, College of Public Health, Epidemiology |
|
402-559-7684 jchan@unmc.edu |
402-559-3848 |
402-559-4957 |
402-559-5387 |
Although scientists at the University of Nebraska Medical Center have been researching cancer since the early 1960s, the national crusade against cancer was mobilized in 1971 when President Richard Nixon signed the National Cancer Act. Over the past quarter century, remarkable advances in cancer research have been attained. In 1996, the National Cancer Institute reported that the cancer death rate in the United States has peaked and, for the first time, begun to fall. This accomplishment comes as a result of the knowledge gained in laboratories and used by scientists and clinicians to develop improved prevention, early detection and diagnosis and treatment strategies.
Despite the tremendous headway made in understanding the biological and chemical processes that cause cancer cells to develop, the search for a cure continues. At the UNMC Eppley Cancer Center, researchers are developing creative research tools to unlock the secrets of this complex disease and devise optimal prevention and treatment strategies.
